BACKGROUND. The observed increase in sojourn time for preclinical breast carcinoma raises the question of whether women age ≥ 65 years can be screened less frequently than younger women. METHODS. A cost-utility analysis using a computer model that simulates tile demography, epidemiology, and natural history of breast carcinoma to estimate expected life-years gained, extra incidence, extra life-years with disease, and costs incurred by different breast carcinoma screening programs in the general population was conducted. RESULTS. The estimated ratio of favorable/unfavorable effects was lower for longer screening intervals compared with shorter screening intervals. The cost-effectiveness ratio was much less favorable in shorter screening intervals. CONCLUSIONS. The results of the current analysis showed that although a longer sojourn time for preclinical breast carcinoma should not necessarily be accompanied by a longer screening interval, a shorter screening interval was not very efficient.
CITATION STYLE
Boer, R., De Koning, H. J., & Van Der Maas, P. J. (1999). A longer breast carcinoma screening interval for women age older than 65 years? Cancer, 86(8), 1506–1510. https://doi.org/10.1002/(SICI)1097-0142(19991015)86:8<1506::AID-CNCR17>3.0.CO;2-2
Mendeley helps you to discover research relevant for your work.